Total Payments
$7,095
2022 Payments
$28.89
Companies
9
Transactions
56
Medicare Patients
512
Medicare Billing
$54,170
Payment Breakdown by Category
Other$3,250 (45.8%)
Food & Beverage$2,167 (30.5%)
Travel$1,678 (23.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,250 | 2 | 45.8% |
| Food and Beverage | $2,167 | 51 | 30.5% |
| Travel and Lodging | $1,678 | 3 | 23.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $5,366 | 6 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $451.89 | 10 | $0 (2019) |
| ABBVIE INC. | $423.97 | 15 | $0 (2022) |
| Intercept Pharmaceuticals, Inc. | $311.24 | 4 | $0 (2017) |
| Ironwood Pharmaceuticals, Inc | $250.98 | 6 | $0 (2019) |
| Gilead Sciences, Inc. | $170.56 | 10 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $68.06 | 3 | $0 (2019) |
| Napo Pharmaceuticals Inc | $35.12 | 1 | $0 (2018) |
| Shire North American Group Inc | $16.67 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $28.89 | 1 | ABBVIE INC. ($28.89) |
| 2020 | $37.33 | 2 | AbbVie Inc. ($37.33) |
| 2019 | $184.56 | 10 | AbbVie, Inc. ($78.17) |
| 2018 | $371.11 | 14 | Merck Sharp & Dohme Corporation ($164.09) |
| 2017 | $6,473 | 29 | Allergan Inc. ($5,366) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/13/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: VIROLOGY | ||||||
| 02/13/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: IMMUNOLOGY | ||||||
| 01/31/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: VIROLOGY | ||||||
| 12/12/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Immunology | ||||||
| 11/19/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/02/2019 | Ironwood Pharmaceuticals, Inc | Linzess (Drug), Viberzi | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: Gastroenterology | ||||||
| 07/15/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/02/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Immunology | ||||||
| 04/22/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/08/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Virology | ||||||
| 02/21/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Immunology | ||||||
| 02/08/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.18 | General |
| 01/25/2019 | Merck Sharp & Dohme Corporation | RENFLEXIS (Biological) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: IMMUNOLOGY | ||||||
| 09/07/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.89 | General |
| 06/27/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.04 | General |
| 06/08/2018 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Virology | ||||||
| 06/01/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.57 | General |
| 03/16/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.93 | General |
| 03/02/2018 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Virology | ||||||
| 02/16/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.20 | General |
| 02/09/2018 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | In-kind items and services | $35.12 | General |
| Category: Antidiarrheal | ||||||
| 02/09/2018 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/02/2018 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/26/2018 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Virology | ||||||
| 01/19/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.71 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 79 | 79 | $64,123 | $11,818 |
| 2022 | 5 | 114 | 136 | $75,970 | $12,580 |
| 2021 | 7 | 174 | 188 | $114,920 | $17,547 |
| 2020 | 5 | 145 | 152 | $80,650 | $12,225 |
Total Patients
512
Total Services
555
Medicare Billing
$54,170
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $29,040 | $6,165 | 21.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 13 | 13 | $25,403 | $3,553 | 14.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $9,680 | $2,100 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 49 | $15,310 | $4,044 | 26.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $17,240 | $3,194 | 18.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $9,180 | $1,985 | 21.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $26,740 | $1,682 | 6.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 25 | $7,500 | $1,675 | 22.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 75 | $23,730 | $6,061 | 25.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 36 | 36 | $19,000 | $4,205 | 22.1% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 15 | 16 | $32,000 | $2,566 | 8.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 19 | 19 | $10,260 | $2,261 | 22.0% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 15 | 15 | $25,050 | $1,427 | 5.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $3,980 | $873.07 | 21.9% |
| 91200 | Measuring the stiffness in the liver via elastography | Office | 2021 | 15 | 15 | $900.00 | $153.90 | 17.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 61 | 61 | $25,800 | $4,053 | 15.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 23 | 23 | $12,800 | $2,381 | 18.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 33 | 39 | $13,050 | $2,106 | 16.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 15 | 16 | $8,640 | $2,069 | 23.9% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 13 | 13 | $20,360 | $1,617 | 7.9% |
About Dr. Jahnavi Sawhney, MD
Dr. Jahnavi Sawhney, MD is a Gastroenterology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1053598227.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jahnavi Sawhney, MD has received a total of $7,095 in payments from pharmaceutical and medical device companies, with $28.89 received in 2022. These payments were reported across 56 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($3,250).
As a Medicare-enrolled provider, Sawhney has provided services to 512 Medicare beneficiaries, totaling 555 services with total Medicare billing of $54,170. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location New York, NY
- Active Since 01/30/2008
- Last Updated 10/15/2018
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1053598227
Products in Payments
- LINZESS (Drug) $5,605
- ZEPATIER (Drug) $311.36
- OCA (Drug) $311.24
- Mavyret (Drug) $159.17
- Viekira (Drug) $143.19
- ZINPLAVA (Biological) $117.45
- XIFAXAN (Drug) $68.06
- Humira (Biological) $55.39
- MAVYRET (Drug) $48.13
- Mytesi (Drug) $35.12
- HUMIRA (Biological) $18.09
- GATTEX (Drug) $16.67
- Linzess (Drug) $11.77
- RENFLEXIS (Biological) $11.38
- ISENTRESS (Drug) $0.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in New York
Arthur Kornbluth, Md, MD
Gastroenterology — Payments: $2.4M
Gastroenterology $2.4M
Dr. David Carr-Locke, Md Frcp Facg Masge, MD FRCP FACG MASGE
Gastroenterology — Payments: $2.3M
Gastroenterology $2.3M
Jean-Frederic Colombel, M.d, M.D
Gastroenterology — Payments: $1.1M
Gastroenterology $1.1M
Dr. Bruce Sands, Md, MD
Gastroenterology — Payments: $1.0M
Gastroenterology $1.0M
Ellen Scherl, Md, MD
Gastroenterology — Payments: $880,329
Gastroenterology $880,329
Sonal Kumar, Md, MD
Gastroenterology — Payments: $769,554
Gastroenterology $769,554